Cargando…
Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1
Adeno-associated virus serotype 2 (AAV-2) has been developed as a gene therapy vector. Antibody and cell-mediated immune responses to AAV-2 or AAV-2-transfected cells may confound the therapeutic use of such vectors in clinical practice. In one of the most detailed examinations of AAV-2 immunity in...
Autores principales: | Madsen, Declan, Cantwell, Emma R., O'Brien, Timothy, Johnson, Patricia A., Mahon, Bernard P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Society for General Microbiology
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885037/ https://www.ncbi.nlm.nih.gov/pubmed/19641045 http://dx.doi.org/10.1099/vir.0.014175-0 |
Ejemplares similares
-
Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy
por: Meumann, Nadja, et al.
Publicado: (2023) -
Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis
por: Bari, Fufa Dawo, et al.
Publicado: (2015) -
Identifying t-cell epitopes of the VP1 capsid protein of human rhinovirus
por: Gaido, Cibele Marina, et al.
Publicado: (2015) -
Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus
por: Asfor, Amin S., et al.
Publicado: (2014) -
Anion-exchange HPLC assay for separation and quantification of empty and full capsids in multiple adeno-associated virus serotypes
por: Khatwani, Santoshkumar L., et al.
Publicado: (2021)